← Open Payments lookup

ROBERT MIMS: Open Payments

NPI 1851303135 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,519 in 57 payments from 6 companies in 2025. Trend: 2023 $1,044 · 2024 $987 · 2025 $1,519

Food & beverage: $1,519
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.23$477
E.R. Squibb & Sons, L.L.C.10$307
Janssen Pharmaceuticals, Inc10$297
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$214
Otsuka America Pharmaceutical, Inc.1$113
Lundbeck LLC5$111

Products named: UZEDY, COBENFY, INVEGA SUSTENNA, CAPLYTA, ABILIFY MAINTENA, ABILIFY ASIMTUFII, AUSTEDO XR.

Industry payments across TX — which companies pay providers there.